ASND
Ascendis Pharma ASNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$14.17B
P/E Ratio
—
EPS
$-4.40
Beta
0.48
52W High
$250.74
52W Low
$150.89
50-Day MA
$231.33
200-Day MA
$210.03
Dividend Yield
—
Profit Margin
-31.70%
Forward P/E
43.86
PEG Ratio
—
About Ascendis Pharma AS
Ascendis Pharma A / S, a biopharmaceutical company, develops therapies for unmet medical needs. The company is headquartered in Hellerup, Denmark.
Fundamentals
| Revenue (TTM) | $720.13M |
| Gross Profit (TTM) | $625.22M |
| EBITDA | $-131.41M |
| Operating Margin | 0.96% |
| Return on Equity | -818.00% |
| Return on Assets | -6.86% |
| Revenue/Share (TTM) | $11.88 |
| Book Value | $-3.11 |
| Price-to-Book | 78.13 |
| Price-to-Sales (TTM) | 19.68 |
| EV/Revenue | 17.15 |
| EV/EBITDA | -20.75 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 42.30% |
| Shares Outstanding | $61.78M |
| Float | $61.38M |
| % Insiders | 0.82% |
| % Institutions | 108.07% |
Historical Volatility
HV 10-Day
46.28%
HV 20-Day
38.70%
HV 30-Day
37.39%
HV 60-Day
38.17%
HV Rank
52.4%
Volatility is currently expanding
Data last updated: 5/1/2026